21 CFR 862.1620
§ 862.1620 Progesterone test system.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 862.1620, § 862.1620 Progesterone test system, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/89171
- Permanent ID
ys:prov:89171@1- SHA-256
bda230706884a3f01b4985e186d730e1004556c8b29acd500e19118211916174
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Identification. A progesterone test system is a device intended to measure progesterone (a female hormone) in serum and plasma. Measurements obtained by this device are used in the diagnosis and treatment of disorders of the ovaries or placenta.
(b) Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.